heterozygous familial hypercholesterolemia HeFH

Related by string. heterozygous familial hypercholesterolemia heFH * Heterozygous : heterozygous familial hypercholesterolemia . heterozygous FH . Heterozygous Familial Hypercholesterolemia / Familial : familial aggregation . familial predisposition / Hypercholesterolemia : homozygous familial hypercholesterolemia . mediated amyloidosis ATTR hypercholesterolemia / heFH : HeFH * *

Related by context. All words. (Click for frequent words.) 60 Atherosclerotic 58 maximally tolerated lipid lowering 57 non splenectomized 57 Hypertensive 57 heterozygous familial hypercholesterolemia 57 hyperphenylalaninemia HPA due 57 unstable angina pectoris 56 Avandia Actos 56 familial hypercholesterolemia FH 56 Thromboembolism 56 de novo kidney transplant 56 atherothrombotic events 56 severe renal insufficiency 56 gestational hypertension 56 Plaquenil 56 chronic myeloid 55 mixed hyperlipidemia 55 Syncria R 55 elevated fasting glucose 55 HIV HCV coinfected 55 chronic rheumatic 55 guanfacine extended release 55 PLX STROKE targeting 55 lowers triglycerides 55 moderate immunologic 55 CLINICAL STUDIES 55 primary hypercholesterolemia 55 moderate renal impairment 55 Meridia sibutramine 55 density lipoprotein HDL cholesterol 55 HeFH 55 diabetic kidney 54 hypertension diabetes mellitus 54 severe Primary IGFD 54 Hypoglycaemia 54 blood glucose concentrations 54 clazosentan 54 T1DM 54 mild hepatic impairment 54 azilsartan medoxomil 54 proliferative retinopathy 54 musculo skeletal pain 54 Lipitor #mg 54 oral antidiabetic medication 54 Myelodysplastic Syndrome MDS 54 exocrine pancreatic insufficiency EPI 54 Tracleer bosentan 54 Primary IGFD 54 Abrupt discontinuation 54 chronic immune thrombocytopenic 54 β blockers 54 severe hepatic insufficiency 54 unstable angina UA 54 orally inhaled migraine 54 polyp recurrence 54 homocysteine concentrations 54 hyperlipemia 54 thromboembolic complications 54 intracerebral haemorrhage 54 Aceon 54 Acute Respiratory Failure 53 acid ethyl esters 53 Chronic Heart Failure 53 elevated uric acid 53 #OHD levels 53 Helicobacter pylori eradication 53 RoACTEMRA 53 fasting triglyceride levels 53 elevated LDL cholesterol 53 silent ischemia 53 prescribe cholesterol lowering 53 thromboembolisms 53 Erythropoietic therapies may 53 myelodysplastic myeloproliferative diseases 53 dyslipidaemia 53 Atypical Hemolytic Uremic Syndrome 53 elevated triglyceride levels 53 hyperlipidaemia 53 glycated hemoglobin levels 53 atherosclerotic renal artery stenosis 53 dual endothelin receptor antagonist 53 Darapladib 53 carotid artery blockage 53 overt nephropathy 53 moderate hepatic impairment 53 thienopyridines 53 hypercholesterolaemia 53 Attention-Deficit/Hyperactivity Disorder ADHD 53 symptomatic intracranial 53 smoldering myeloma 53 treat secondary hyperparathyroidism 53 CTAP# Capsules 53 NIASPAN 53 familial hypercholesterolemia 53 serum phosphate 53 AVAPRO 53 Heterozygous Familial Hypercholesterolemia 53 lowering blood glucose 53 NYHA classification 53 ezetimibe Zetia 53 GH deficiency 53 Subgroup Analysis 53 juvenile idiopathic arthritis JIA 53 antiphospholipid antibodies 53 ACTEMRA TM 53 evaluating CK # 53 mild renal insufficiency 53 HIV treatments Reyataz 53 Olmesartan medoxomil 53 aliskiren amlodipine 53 Juvenile Idiopathic Arthritis 53 containing abacavir 53 atopic asthma 53 ® lenalidomide 53 elevated prolactin 53 inversely associated 53 ATACAND 53 Phenylketonuria PKU 53 grade cervical dysplasia 53 ischemic vascular 53 Vitamin D supplementation 53 undergo percutaneous coronary 53 nonfasting triglyceride levels 53 glycosylated hemoglobin levels 53 artery stenosis 53 lamotrigine Lamictal 53 benazepril 52 Artificial pancreas 52 severe hypoglycaemia 52 deep venous thromboses 52 CETP inhibition 52 serum uric acid 52 secondary hyperparathyroidism 52 hypertension PAH 52 postoperative AF 52 nonalcoholic steatohepatitis NASH 52 refractory myeloma 52 chronic thromboembolic pulmonary 52 persistent pulmonary hypertension 52 bone marrow reticulin deposition 52 cardiovascular calcification 52 deletion 5q 52 undergoing peritoneal dialysis 52 bladder carcinoma 52 angiotensin receptor blockers ARB 52 Hyperlipidemia 52 refractory colorectal cancer 52 induce orthostatic hypotension 52 anticlotting drugs 52 cardiovascular morbidity 52 Ph + acute lymphoblastic 52 Roche Herceptin 52 SORT OUT III 52 EFFEXOR XR 52 PRADAXA #mg 52 rheumatoid arthritis psoriatic arthritis 52 stimulates insulin secretion 52 TNF alpha antagonist 52 channel blocker amlodipine 52 losartan Cozaar 52 immune thrombocytopenic purpura ITP 52 atopic disease 52 plasma triglycerides 52 Paxil paroxetine 52 intracranial atherosclerosis 52 hypokalemia hypomagnesemia 52 preserved ejection fraction 52 Femara letrozole 52 hemoglobin A1c levels 52 candesartan cilexetil 52 euthyroid 52 LVSD 52 comorbid depression 52 purpura ITP 52 resected pancreatic cancer 52 Exacerbation 52 alfuzosin 52 improves insulin sensitivity 52 abnormal lipid levels 52 infliximab monotherapy 52 Acute Renal Failure 52 Muraglitazar 52 Her2 positive 52 hepatorenal syndrome 52 Bronchopulmonary Dysplasia 52 elevated hsCRP 52 Potiga 52 #.#mmol L [002] 52 Pegylated interferon 52 subclinical hypothyroidism 52 plus COPEGUS 52 patients undergoing percutaneous 52 basal bolus therapy 52 grade glioma 52 Febuxostat 52 triacylglycerol concentrations 52 advanced hepatocellular carcinoma 52 beta blocker therapy 52 antiphospholipid syndrome 52 Atomoxetine 52 hypercalciuria 52 bolus dosing 52 primary hyperparathyroidism 52 SIADH 52 systemic hypotension 52 antithyroid 52 underwent liver transplantation 51 Combination therapy 51 propranolol Inderal 51 systemic juvenile idiopathic 51 eosinophilic asthma 51 C1 INH deficiency 51 PARGLUVA 51 diastolic blood pressures 51 norepinephrine reuptake inhibitor 51 Intravitreal 51 insulin glulisine 51 opioid dependent 51 variant angina 51 ribavirin USP 51 leukemia multiple myeloma 51 Phenylketonuria 51 Diamyd r 51 bladder ovarian 51 perioperatively 51 5-fluorouracil/leucovorin 51 Hp2 2 51 pioglitazone hydrochloride 51 lanthanum carbonate 51 MELAS 51 nondiabetic patients 51 valsartan amlodipine 51 aspirin clopidogrel 51 tHcy 51 homozygous familial hypercholesterolemia 51 allogeneic HSCT 51 inhaled budesonide 51 dose statin therapy 51 colon rectal 51 Systemic Juvenile Idiopathic 51 selective cyclooxygenase 2 51 AA Amyloidosis 51 Arranon 51 Thromboembolic 51 diabetic gastroparesis 51 Paroxysmal Nocturnal Hemoglobinuria 51 Cardiovascular Outcomes 51 venlafaxine Effexor 51 DPP4 inhibitor 51 polycythemia vera essential thrombocythemia 51 Cancidas 51 serum IGF 51 neutropenic sepsis 51 Mevacor lovastatin 51 NSAID associated 51 Lopid 51 known sulfonamide allergy 51 transferrin saturation 51 dose clopidogrel 51 inhaled corticosteroids ICS 51 Levels Linked 51 thromboxane A2 51 serum estradiol 51 metformin sulfonylurea 51 Atacand 51 Behçet disease 51 anticholinergic agents 51 1 proteinase inhibitor 51 Relapsing Remitting Multiple Sclerosis 51 severe mitral regurgitation 51 Crestor rosuvastatin 51 hyperglycaemia 51 overactive bladder syndrome 51 de novo AML 51 pancreatic insufficiency 51 lipid elevations 51 Acute Coronary Syndromes ACS 51 Gene Mutation Linked 51 Bondronat 51 baseline Hb 51 selective modulator 51 NovoRapid 51 corticosteroid induced 51 retinal vein occlusion induced 51 Nonalcoholic Fatty Liver Disease 51 smoldering multiple myeloma 51 thrombocytopenic 51 insulin secretagogues 51 Systemic Sclerosis 51 Hypertriglyceridemia 51 ACTOplus met XR 51 Reminyl galantamine 51 Refractory Hodgkin Lymphoma 51 chronic granulomatous disease 51 N Engl J 51 beta carotene supplementation 51 antiarrhythmic drug 51 lowers LDL cholesterol 51 non splenectomised 51 humanized interleukin 6 51 abnormal lipids 51 carotid atherosclerosis 51 thyroid hormone replacement 51 lipid lowering agents 51 direct renin inhibition 51 sulfonylurea metformin 51 Serdolect 51 Natalizumab 51 anti arrhythmic drug 51 Temodar ® 51 Impaired glucose tolerance 51 mitoxantrone plus 51 evaluate ZFP Therapeutic 51 thetreatment 51 triglyceride concentrations 51 AstraZeneca Plc Crestor 51 advanced metastatic HER2 51 Amgen Vectibix 51 Crohn colitis 50 ischemic cardiovascular 50 urinary cortisol 50 rheumatoid arthritis inflammatory bowel 50 ACE Inhibitor 50 postprandial glycemia 50 dose ritonavir 50 atherosclerotic cardiovascular disease 50 obese postmenopausal 50 HMG CoA reductase inhibitors 50 Clot busting 50 G6PD deficiency 50 colorectal adenoma 50 venlafaxine XR 50 quetiapine Seroquel 50 hoFH 50 generalized anxiety disorder GAD 50 myelodysplastic syndromes MDS 50 severe malignant osteopetrosis 50 coronary artery atherosclerosis 50 metformin sulphonylurea 50 Coronary artery calcification 50 total cholesterol triglycerides 50 nonfatal stroke 50 metformin XR 50 exercise induced bronchoconstriction 50 Long Term Efficacy 50 Lubiprostone 50 dose atorvastatin 50 lymphomas leukemias 50 crohn disease 50 intravenous RSD# 50 restenosis reblockage 50 Hydroxyurea 50 folinic acid 50 osteopenic 50 Kidney Disease Outcomes 50 hereditary antithrombin deficient 50 approved incretin mimetic 50 Sjogren Syndrome 50 angiotensin receptor 50 serum LDL cholesterol 50 CVD mortality 50 Paroxysmal Nocturnal Hemoglobinuria PNH 50 bronchopulmonary dysplasia BPD 50 Zortress 50 Microalbuminuria 50 mildly symptomatic 50 Neovascular Age Related Macular 50 NIDDM 50 active ankylosing spondylitis 50 TTF Therapy 50 beta blockers ACE inhibitors 50 diuretics beta blockers 50 Vildagliptin 50 Denufosol 50 Acamprosate 50 Chronic ITP 50 XIENCE V demonstrated 50 TOVIAZ 50 8mg/kg 50 stratifying patients 50 retinal vein occlusion 50 troponin T 50 IMiDs ® 50 kidney insufficiency 50 genitourinary GU 50 oxaliplatin Eloxatin 50 Stent thrombosis 50 atherosclerotic cardiovascular 50 non resectable metastatic 50 acitretin 50 pulmonary hypertension PH 50 aldosterone antagonists 50 decompensated liver disease 50 perinatal morbidity 50 Peginterferon alfa 2b 50 AVANDIA 50 Inhaled nitric oxide 50 abnormal genital 50 SGPT 50 baseline HbA1c 50 LHRH receptor positive 50 relapsed MM 50 cardiovascular mortality 50 Arrhythmias 50 ® pioglitazone HCl 50 neurodevelopmental impairment 50 Pioglitazone 50 coronary vascular 50 type 1diabetes 50 sulphonylurea 50 Multidrug 50 CC genotype 50 non valvular atrial 50 Adjunctive 50 interstitial pneumonia 50 venous thromboembolic events 50 Celebrex celecoxib 50 Triptan 50 NATRECOR R 50 Laquinimod 50 Henrik Leffers 50 induce ovulation 50 alpha1 antitrypsin deficiency 50 intensive statin therapy 50 arterial hypertension 50 acute decompensated heart 50 IOP lowering 50 gastro oesophageal reflux 50 decompensated heart failure 50 Homocysteine levels 50 comorbid anxiety 50 recurrent atrial fibrillation 50 Slows Progression 50 abacavir Ziagen 50 Renal Impairment 50 adalimumab Humira 50 riociguat 50 Adjuvant Treatment 50 Chronic Myeloid Leukemia 50 stable angina pectoris 50 induced anemia 50 Relapsed Refractory 50 indicates cardio circulatory 50 Hormone Refractory Prostate Cancer 50 Abstract P# [002] 50 Investigational Treatment 50 intracranial haemorrhage 50 Newly Diagnosed Multiple Myeloma 50 attain statistical significance 50 nonfatal myocardial infarction MI 50 low ptau levels 50 metastatic malignant 50 Pirfenidone 50 Malignant Glioma 50 mutated K ras 50 Delayed Graft Function 50 Primary Hypercholesterolemia 50 steroid refractory GvHD 50 CIMZIA TM certolizumab pegol 50 Unstable Angina 50 convulsive disorders 50 Perindopril 50 Proteinuria 50 chronically immunosuppressed solid 50 Hyperphosphatemia 50 embolic stroke 50 cervical dystonia CD 50 #-# Full Text 50 bisoprolol 50 N telopeptide 50 eluting stent 50 pralatrexate PDX 50 serum urate levels 50 Fluid retention 50 Insulin detemir 50 Nonalcoholic Steatohepatitis 50 fructose intolerance 50 pulmonary arterial hypertension 50 ß blockers 50 hypercholesterolemia 50 confidence interval #.#-#.# 50 lowering triglycerides 50 hour bronchodilation 50 Tredaptive 50 nitroprusside 50 lowering homocysteine levels 50 BENICAR 50 Patients Treated With 50 mycophenolic acid 50 fetuin 50 non cirrhotic portal 50 nulliparous women 50 Overactive Bladder OAB 50 asthma rheumatoid arthritis 50 heFH 50 chronic myocardial ischemia 50 null responder 50 Aryplase 50 adjunctive placebo 50 ovarian carcinoma 50 inhaled iloprost 50 Fasting glucose 50 parecoxib 50 hsCRP levels 50 Polyneuropathy 50 receiving XGEVA 50 relapsed acute lymphoblastic 50 antiretroviral naïve 50 minimally symptomatic 50 multivariable adjusted 50 Hypercholesterolemia 50 mcg BID 50 LHON 50 recurrent venous thromboembolism 50 fluorouracil leucovorin 50 adiponectin concentrations 50 #/#mmHg 50 testicular germ cell 50 nadroparin 50 dyslipidemic 50 anticoagulants blood thinners 50 aripiprazole Abilify 50 alendronate Fosamax 50 fasting plasma glucose FPG 50 aminotransferase ALT 50 MULTAQ 50 Stop Hypertension DASH diet 50 LCP Tacro 50 tricyclic antidepressants TCAs 50 olanzapine LAI 50 Reduces Mortality 50 Pamidronate 50 symptomatic VTE 49 folate concentrations 49 teriflunomide 49 glitazone 49 underwent percutaneous coronary 49 fluvoxamine Luvox 49 Monopril 49 elevated homocysteine 49 predisposing factor 49 systemic corticosteroid 49 salmeterol fluticasone 49 thromboembolic disease 49 fistulizing CD 49 elevated creatinine 49 Postmenopausal 49 Almorexant 49 uterine fibroids endometriosis 49 acute lymphoblastic 49 receiving CIMZIA #mg 49 Gheorghiade 49 titrated glipizide plus 49 Flomax tamsulosin 49 Soy isoflavones 49 rabeprazole 49 evaluating mipomersen 49 NYHA Class II 49 TNF Tumor Necrosis Factor 49 Plendil 49 relapsed Acute Myeloid 49 M# rationally 49 subsyndromal 49 HDL cholesterol triglycerides 49 Slow Progression 49 interferon alfa 2b 49 BARACLUDE ® 49 thyrotropin levels 49 veno occlusive disease 49 detemir 49 chronic idiopathic thrombocytopenic purpura 49 reuptake inhibitor 49 Acute Coronary Syndrome 49 variable ptau levels 49 severe exacerbations 49 Azacitidine 49 Zyban bupropion 49 SHPT 49 onset atrial fibrillation 49 dermatologic reactions 49 soluble CD# ligand 49 formerly LymphoStat B 49 nonischemic 49 taxane refractory 49 cinacalcet 49 cardiovascular disease osteoporosis 49 NYHA Class IV 49 trauma malignant tumors 49 onset diabetes mellitus 49 Noxafil 49 humanized therapeutic 49 uric acid levels 49 nondiabetics 49 platelet inhibitor 49 hyperglycaemic 49 fistulizing Crohn disease 49 highest tertile 49 RNAi therapeutic targeting PCSK9 49 urate levels 49 pravastatin therapy 49 Postmenopausal hormone therapy 49 angiotensin II receptor blockers 49 osteopenia osteoporosis 49 BENICAR HCT 49 insulin sulfonylureas 49 serum phosphorous 49 psoriatic arthritis PsA 49 pulmonary artery hypertension 49 abnormal lipid 49 corticosteroid dexamethasone 49 pre eclamptic 49 undetectable viral 49 recurrent glioblastoma multiforme 49 Pramlintide 49 Lantus insulin 49 intracerebral hemorrhage ICH 49 bivalirudin alone 49 invasive candidiasis 49 fluticasone salmeterol 49 Lupus Nephritis 49 everolimus tablets 49 angiogenic therapy 49 daily subcutaneous injections 49 basal cell nevus syndrome 49 preterm neonates 49 autoantibody positive 49 hemoglobin A1c HbA1c 49 metastatic renal 49 elevated CRP 49 SERCA2a 49 FTY# fingolimod 49 Ramipril 49 QNEXA 49 GnRH agonist 49 MPGN 49 prescribed proton pump 49 Implantable lenses 49 Robert Vigersky 49 postprandial blood glucose 49 NYHA class 49 infarction NSTEMI 49 systolic hypertension 49 Renal Insufficiency 49 hypercholesterolemic 49 fluvastatin 49 Known generically 49 Hormone pills 49 Vidaza azacitidine 49 transfusion syndrome 49 Danazol 49 oncologic diseases 49 Relapsing Multiple Sclerosis 49 oral renin inhibitor 49 thiazide diuretics 49 Paliperidone Palmitate 49 Intervention Effectiveness 49 Scandinavian Simvastatin Survival 49 meta analytic review 49 CINQUIL 49 micronized progesterone 49 cryptogenic 49 nonalcoholic steatohepatitis 49 opioid naive 49 zoledronic acid Reclast 49 oral antiplatelet therapy 49 clevidipine 49 VesCell ™ 49 PPCM 49 monozygotic twin 49 fasting glucose levels 49 Bosentan 49 ViaDerm hPTH #-# 49 Anti psychotics 49 hypothalamic amenorrhea 49 myocardial infarction ventricular fibrillation 49 underactive thyroid gland 49 dyslipidemia hypertension diabetes 49 acetaminophen ibuprofen 49 Phase III multicenter 49 darbepoetin alpha 49 pulmonary arterial hypertension PAH 49 generation purine nucleoside 49 undergoing coronary angiography 49 atherothrombosis 49 ® natalizumab 49 glycosylated hemoglobin HbA1c 49 administered intramuscularly 49 aspirin heparin 49 TAXUS p value 49 Naive Patients 49 E selectin 49 Severe Primary IGFD 49 labetalol 49 hematological parameters 49 Onglyza saxagliptin 49 Commonly prescribed 49 abnormal glucose tolerance 49 Severe hypoglycemia 49 hyperinsulinemic 49 acarbose 49 Epanova 49 associated gastric ulcers 49 Zemplar Capsules 49 serum parathyroid hormone 49 undergoing coronary bypass 49 monoamine oxidase inhibitor 49 Sipuleucel T 49 immunosuppressive regimen 49 Idiopathic Pulmonary Fibrosis IPF 49 Chemotherapy induced 49 stage IIIb 49 familial hypercholesterolaemia 49 elevated blood glucose 49 Angiotensin Converting Enzyme 49 R entecavir 49 1c HbA 1c 49 A1PI 49 pravastatin Pravachol 49 unresectable tumors 49 mmol l 49 impaired glucose metabolism 49 Lipitor atorvastatin 49 ergot derivatives 49 myocardial infraction 49 ischemic cardiomyopathy 49 Arteriosclerosis 49 APPRAISE 49 Alport syndrome 49 bronchial hyperresponsiveness 49 diabetes dyslipidemia 49 sitaxsentan 49 progressively degenerative 49 secondary amenorrhea 49 Occlusive Disease 49 Polycystic Ovary Syndrome 49 prostate cancer CRPC 49 folate vitamin B 49 Basal Cell 49 allogeneic hematopoietic cell 49 multivessel disease 49 FRDA 49 Amgen Neulasta R 49 Fondaparinux 49 Oropharyngeal Candidiasis 49 HIV lipodystrophy 49 HbA1C 49 Lancet Neurology 49 TNF alpha inhibitor 49 Treatment Naive Patients 49 plus octreotide LAR 49 underactive thyroids 49 STRIDE PD 49 dyslipidemia abnormal 49 ibuprofen diclofenac 49 NICE Recommends 49 Evoltra ® 49 Major Depressive Disorder 49 oral aromatase inhibitor 49 antidiabetic drug 49 NNT = 49 atherosclerotic vascular disease 49 vaso occlusive crisis 49 Prednisone Against Refractory 49 topical calcineurin inhibitors 49 plasma lipids 49 Treating Heart Failure 49 Improves Outcomes 49 diastolic heart 49 Acneform rash occurred 49 bronchopulmonary dysplasia 49 oral anticoagulant agent 49 infliximab Remicade 49 Cholesterol lowering 49 diabetic peripheral neuropathy DPN 49 hyperlipidemic 49 Tolerability 49 #mg/day [001] 49 refractory anaplastic astrocytoma 49 hematopoietic cancers 49 serum calcium levels 49 squamous cell lung cancer 49 IDDM 49 PYY nasal spray 49 ACE inhibitors ARBs 49 irbesartan 49 serum folate concentrations 49 isolated systolic hypertension 49 uterine fibroid induced 49 sodium valproate 49 thiazide 49 abacavir lamivudine 49 receiving VELCADE 49 Amgen Neulasta ® 49 epirubicin cisplatin 49 paricalcitol 49 oral hypoglycemic agent 49 ibandronate 49 attention-deficit/hyperactivity disorder ADHD 49 heparin induced thrombocytopenia 49 postoperative atrial fibrillation 49 systolic dysfunction 49 Uncontrolled hypertension 49 omacetaxine mepesuccinate 49 Idiopathic Pulmonary Fibrosis 49 echocardiographic parameters 49 fat malabsorption 49 Belldegrun 49 Angiotensin II 49 dose intramuscular 49 comorbid illnesses 49 ritonavir boosted 49 Rebif interferon beta 1a 49 refractory metastatic colorectal cancer 49 leukemia AML 49 Rheos System 49 Chronic Obstructive Pulmonary 49 LDL cholesterol HDL cholesterol 49 thromboembolic events 49 Interferon Beta 49 mL/min/#.# m 2 49 macrovascular disease 49 urolithiasis 49 antioxidant supplementation 49 Myelodysplasia 49 colesevelam 49 Nesiritide 49 coronary blockages 49 subependymal giant cell 49 REBETOL combination 49 elevated triglycerides 49 estradiol gel indicated 49 inhibits blood clotting 49 Afib 49 myocardial infarctions MIs 49 #:#-# [031] 49 THALOMID ® 49 INSPIRE Trial Phase III 49 HDL Cholesterol 49 Certolizumab pegol 49 Homocysteine 49 #mm Hg 49 Vitamin D supplements 49 myeloid metaplasia 49 treatmentof 49 Intra arterial 49 leukemia lymphoma multiple myeloma 49 Bronchiectasis 49 hyperphosphataemia 49 Elevated serum 49 Chronic Idiopathic Constipation 49 antiarrhythmic 49 thrombotic events 49 vitamin B1 deficiency 49 Shows Promise Against 49 hepatocellular carcinoma liver 49 dose cytarabine 49 SNT-MC#/idebenone 49 Complicated Skin 49 Boniva ibandronate 49 clobazam 49 controlled dose escalation 49 briakinumab 49 valvular heart disease 49 atypical hemolytic uremic syndrome 49 haemorrhagic stroke 49 serum sodium levels 49 Cell Lymphoma CTCL 49 FOLFOX6 chemotherapy regimen 49 normotensive 49 triglycerides ≥ 49 R abatacept 48 arterial calcification 48 Lipoprotein 48 Enhanced External Counterpulsation 48 undergoing liver transplantation 48 LV dysfunction 48 cortisol secretion 48 reduce serum phosphate 48 Macular edema 48 Calcium intake 48 imipramine Tofranil 48 meropenem 48 colorectal liver metastases 48 drug eluting stent implantation 48 postoperative delirium 48 Multiethnic Study 48 atherogenic dyslipidemia 48 Losartan 48 calcium antagonists 48 macrovascular events 48 paroxysmal nocturnal hemoglobinuria PNH 48 antiarrhythmic drugs 48 nonnucleoside reverse transcriptase inhibitors 48 autologous transplants 48 cardiometabolic diseases 48 PCI percutaneous coronary 48 basal insulin analogue 48 Generalized Anxiety Disorder GAD 48 Brilique 48 ASK DR 48 HbA 1c levels 48 platelet inhibition 48 AstraZeneca Iressa 48 weight heparin LMWH 48 metastatic colorectal carcinoma 48 Myelodysplastic syndromes 48 Myelodysplastic Syndrome 48 Zavesca 48 vitreous floaters 48 Angina pectoris 48 CTAP# 48 Patients Receiving 48 inhaled bronchodilators 48 idiopathic thrombocytopenic purpura 48 DMSA 48 anovulation 48 Actonel risedronate 48 journal Clinical Gastroenterology 48 hypoxic ischemic encephalopathy HIE 48 SUSTENNA TM 48 prescribed antipsychotics 48 abdominal adiposity 48 cetilistat 48 Ferinject R 48 contains sulfonylurea hypoglycemia 48 Arch Intern Med 48 metastatic uveal melanoma 48 acute myeloid 48 sulfonylurea glimepiride 48 ELIQUIS 48 CYP#D# inhibitor 48 epoetin alpha 48 vulvovaginal atrophy 48 latent celiac disease 48 Magnesium deficiency 48 Solesta TM 48 placebo controlled dose escalation 48 lowest tertile 48 gm dL 48 docetaxel Injection Concentrate 48 type2 diabetes 48 islet autoimmunity 48 interstitial nephritis 48 nephropathic cystinosis cystinosis 48 folic acid vitamin B# 48 Gastrointestinal GI 48 patients receiving myelosuppressive 48 polytherapy 48 Kinoid 48 thrombo embolic 48 probiotic supplementation 48 unexplained vaginal bleeding 48 Myfortic 48 Parkinson Disease PD 48 pulmonary fungal infections 48 mild renal impairment 48 Norvasc amlodipine 48 NYHA functional class 48 serum GGT 48 tenofovir emtricitabine 48 Aviptadil 48 erythematosus 48 5mg dose 48 Roche MabThera 48 lipid lowering drugs 48 cerebrovascular disorders 48 LC#m# vaccine 48 antipsychotics antidepressants 48 Ovary removal 48 oral anticoagulation 48 polycystic 48 autoimmune thyroiditis 48 GW# [003] 48 APIDRA R 48 azilsartan 48 Decitabine 48 postmenopausal hormone replacement 48 Late Breaker 48 elevated troponin 48 piroxicam 48 hypertensives 48 HYVET 48 demonstrated antitumor activity 48 Certican 48 Non Alcoholic Fatty 48 Amgen Nplate 48 Myocarditis 48 angiotensin II receptor blocker 48 resistant hormone refractory 48 microvascular function 48 denileukin diftitox 48 serum calcium 48 hypercholesterolemic patients 48 dose interleukin 48 Perinatal Epidemiology 48 Veno Occlusive Disease 48 ruboxistaurin 48 valvular disease 48 Novo Nordisk NOVOb.CO

Back to home page